XETRA - Delayed Quote EUR

Medtronic plc (2M6.DE)

74.11

-0.13

(-0.18%)

At close: 5:35:41 PM GMT+2

This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy

Medtronic's revenue growth has been relatively unimpressive in recent years. There are other reasons to invest in Medtronic, including its rock-solid dividend program. Medical device specialist Medtronic (NYSE: MDT) has not performed well over the past five years; the stock has significantly lagged broader equities.

Motley Fool 2 days ago

MDT
Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

Medtronic (MDT) closed the most recent trading day at $84.85, moving +1.54% from the previous trading session.

Zacks 2 days ago

MDT

^GSPC
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Key Insights Medtronic's estimated fair value is US$92.22 based on 2 Stage Free Cash Flow to Equity With US$83.56 share...

Simply Wall St. 3 days ago

MDT
Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic (MDT) concluded the recent trading session at $84.76, signifying a +0.19% move from its prior day's close.

Zacks 4 days ago

MDT

^GSPC
Medtronic Education Program Opens Doors for Employees

Illness in the family sparked Christopher Hibbler's interest in medicine. Our MAPS program is helping make his dream come true NORTHAMPTON, MA / ACCESS Newswire / April 30, 2025 / No one knew it at the time, but Christopher Hibbler's grandparents ...

ACCESS Newswire 5 days ago

MDT
Medtronic wins FDA approval for defibrillation lead

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, according to Medtronic.

MedTech Dive 5 days ago

MDT
Medtronic reinvents surgical training for a new era

The medical device giant is continuing to evolve its surgical training provision to chime with the dynamism necessary for modern surgical training.

Medical Device Network 6 days ago

MDT
4 PFA studies in the spotlight at Heart Rhythm 2025

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm Society’s annual meeting.

MedTech Dive 6 days ago

MDT

BSX

JNJ
The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic

Abbott Laboratories, Boston Scientific and Medtronic are included in this Analyst Blog.

Zacks 7 days ago

ABT

BSX

MDT
Medtronic submits Hugo soft tissue robot for FDA approval

William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful U.S. competition.

MedTech Dive 7 days ago

MDT
Medtronic’s defibrillation lead gains FDA approval for use in right ventricle

The lead is intended for use in adults and adolescent paediatric individuals who are aged 12 years and above.

Medical Device Network 7 days ago

MDT
Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Affera™ family of technologies, including the next-generation Sphere-360™ single-shot pulsed field ablation (PFA) catheter and the groundbreaking Sphere-9™ combination mapping and dual-energy focal PFA catheter. Data were presented in High Impact Science Sessions at the Heart Rhythm Society 2025 Annual Meeting in

PR Newswire 8 days ago

MDT
2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. With that, let's consider two dividend-paying companies that look like strong buys for the next two decades: Medtronic (NYSE: MDT) and Merck (NYSE: MRK). Medtronic, a leader in medical devices, could feel the impact of President Trump's tariffs.

Motley Fool 8 days ago

MDT
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption (IDE) clinical study, the largest such study for robotic-assisted urologic surgery ever conducted, met both primary safety and effectiveness endpoints. The prospective, multi-center, single-arm IDE study included 137 patients who underwent urologic procedures using the Hugo™ robotic-assisted surgery (RAS) system.

PR Newswire 8 days ago

MDT
Medtronic (NYSE:MDT) Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead

Medtronic (NYSE:MDT) recently announced FDA approval of its OmniaSecure™ defibrillation lead, marking a key advancement in cardiovascular technology, along with results from its LEADR LBBAP study showing a 100% defibrillation success rate. Over the past week, Medtronic's stock price increased by 1.9%, a move that aligned with these positive developments but was modest compared to the broader market's 4.7% rise. While Medtronic's innovative product developments could have added weight to its...

Simply Wall St. 8 days ago

MDT
Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for the OmniaSecure™ defibrillation lead for placement within the right ventricle. The lead, built on the highly reliable SelectSecure™ Model 3830 pacing lead and delivered via catheter, builds on the Medtronic portfolio of lead solutions designed for precise delivery and placement. The lead connects to an implantable defibrillator, and treats potentially life threatenin

PR Newswire 9 days ago

MDT
Medtronic to distribute Dragonfly Endoscopy’s pancreaticobiliary system in US

Medtronic plans to launch the system across select clinical and academic centres in the country starting this year.

Medical Device Network 10 days ago

MDT
The Smartest Dividend Stocks to Buy With $2,000 Right Now

Buying dividend stocks is always a smart plan. The best returns have come from dividend growers (10.2% annual returns). Four top dividend growers are Realty Income (NYSE: O), Brookfield Infrastructure (NYSE: BIPC)(NYSE: BIP), PepsiCo (NASDAQ: PEP), and Medtronic (NYSE: MDT).

Motley Fool 10 days ago

O

MDT

BIP-P-A
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

Medtronic (MDT) reachead $84.30 at the closing of the latest trading day, reflecting a +0.66% change compared to its last close.

Zacks 10 days ago

MDT
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.

MedTech Dive 11 days ago

MDT

Performance Overview

Return	2M6.DE	S&P 500 (^GSPC)
YTD	-3.50%	-3.57%
1-Year	+1.37%	+10.60%
3-Year	-16.86%	+36.77%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medtronic plc (2M6.DE)

This Magnificent High-Yield Dividend Stock Just Became an Even Better Buy

Medtronic (MDT) Surpasses Market Returns: Some Facts Worth Knowing

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Medtronic (MDT) Rises Higher Than Market: Key Facts

Medtronic Education Program Opens Doors for Employees

Medtronic wins FDA approval for defibrillation lead

Medtronic reinvents surgical training for a new era

4 PFA studies in the spotlight at Heart Rhythm 2025

The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic

Medtronic submits Hugo soft tissue robot for FDA approval

Medtronic’s defibrillation lead gains FDA approval for use in right ventricle

Medtronic Affera™ pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients

2 Outstanding Dividend Stocks to Buy and Hold For 20 Years

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system

Medtronic (NYSE:MDT) Secures FDA Approval For Innovative OmniaSecure Defibrillation Lead

Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results

Medtronic to distribute Dragonfly Endoscopy’s pancreaticobiliary system in US

The Smartest Dividend Stocks to Buy With $2,000 Right Now

Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know

Medtronic seeks FDA nod for insulin pump, furthering Abbott collab

Performance Overview